News Focus
News Focus
icon url

pphmtoolong

03/24/14 10:29 AM

#168928 RE: corporalagarn #168891

Once again I find myself agreeing with you. Not a common thing for me. However, I too have the sense that Chris Keenan could show a kinder, gentler attitude to shareholders. I understand the "we are focused on the science and plan execution, and that should be enough attitude".

However, it seems to me that a "we understand that shareholders own the company and we want them to know that we do have their interests at heart" approach costs Peregrine management nothing and reassures those of us risking cash on them.

Having said the above, I am sticking with Peregrine because I like how they have moved Bavi forward, and I believe they can get us a good deal in a partnership or buyout. It will not be a warm and fuzzy feeling of comradeship with management, but a lucrative financial boost when/if they can succeed.

GLTA, Paul
icon url

Threes

03/24/14 12:54 PM

#169058 RE: corporalagarn #168891

Are you kidding me when you say :

"He also seemed overly concerned about a complaint to the SEC. If your house is clean, you really shouldn't be too concerned."

I pay my taxes and am not hiding anything ,but, I would not l would not want the IRS to audit me. That takes valuable time , and expense. It is unsettling because if the auditor is wacky or has an agenda I am @@$$ed. Do you think the SEC is a bunch of backslapping happy go lucky guys.
They are government red tape heavy, interpretation cloudy, heavy handed on some and non existent to others. Once that pandoras box is open no one knows what damage will be inflicted.
Also just let them start an official investigation and see what the SP does when that little gem gets PR. Why not just go out a shot yourself in the face.

As far as the "if you don't like it leave" that has been the PPHM attitude as long as I can remember. I used to resent it ,but, no longer.
They have navigated through so many obstacles while always moving forward. It is not the norm for a small underfunded Biotech to have been able to get this far with the science, have a qualified Manufacturing facility, peer reviewed acceptance of a novel technology, the IST to help move the science while limiting cash burn, oars in the water for imaging, viral, and multiple cancers.
If you can't see there progress and don't have the stomach for the trek they are right get out.
They can't waiver and succumb to everyone way of doing things, If so they would change course very 10 minutes and get nowhere.
Have they never made a mistake, sure plenty, but we are at this point and moving forward as fast as possible.
In the world of science and BKT the process is measured in years, the mountain is high, IF you get to the summit the view is awesome.
We are just not there yet, we are closer then before and still climbing.
Just hope NSCLC rope doesn't break in the next trial, hope liver has more to offer then the obscure crap they feed us in the last PR.
Are they sandbagging liver for AACR or is just not as good as we would like it to be.
Garnick hasn't killed it yet and they are continuing with the topic in an upcoming oral presentation. In PPHM land it's a coin toss what to think.
I don't even want o bring up BB's, they are going to be the better mousetrap. I would hope they keep it in obscurity until Bavi is monitized.
It may be a big step forward and 10 years backward at the same time.

Anyway bottom line if you have a death wish call in the SEC, If you think you can do a better job running a BKT start one, because this ship will sail as it sees fit.
If you think the ship will discover the promised land hold . If not sell.
Don't think for a minute this BOD is asking for our advise or gives rats ass what we think as far as running the company.
Remember they know the whole story we only have theories.